nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2025-6-120-126nnp-2747Research ArticleREVIEWSОБЗОРЫCognitive impairment following strokeКогнитивные нарушения после острых нарушений мозгового кровообращенияhttps://orcid.org/0000-0002-7465-0677ПизоваН. В.PizovaN. V.

Наталия Вячеславовна Пизова - Кафедра нервных болезней с медицинской генетикой и нейрохирургией.

150000, Ярославль, ул. Революционная, 5

pizova@yandex.ruhttps://orcid.org/0000-0002-0522-675XПизовА. В.PizovA. V.

Кафедра методики преподавания естественно-математических дисциплин в начальной школе.

150000, Ярославль, ул. Республиканская, 108/1

Department of Methods of teaching Natural Sciences and Mathematics in primary schools.

108/1, Respublikanskaya St., Yaroslavl 150000

ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России, ЯрославльРоссияYaroslavl State Medical University, Ministry of Health of RussiaRussian FederationФГБОУ ВО «Ярославский государственный педагогический университет им. К.Д. Ушинского», ЯрославльРоссияYaroslavl State Pedagogical University named after K.D. UshinskyRussian Federation202520122025176120126Copyright © Pizova N.V., Pizov A.V., 20252025Пизова Н.В., Пизов А.В.Pizova N.V., Pizov A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/2747

Stroke is one of the leading causes of death and disability worldwide. Post-stroke cognitive impairment (PSCI), characterised as a decline in cognitive function following a stroke, can range from mild deficits to dementia and is a common and serious long-term consequence of stroke. CI can develop after both ischemic and hemorrhagic strokes. The risk and timing of PSCI may depend on various factors. The presence of PSCI is independently associated with a lower quality of life after stroke and higher mortality. Understanding the pathogenesis of PSCI is fundamental to reducing the global burden of stroke. Treatment of PSCI involves a multidisciplinary approach to addressing the underlying causes and cognitive symptoms. Management strategies focus on cognitive rehabilitation, pharmacological interventions, and the elimination of modifiable risk factors.

Инсульт является одной из основных причин смертности и инвалидности во всем мире. Постинсультные когнитивные нарушения (ПИКН), которые характеризуются как ухудшение когнитивных функций после инсульта, могут варьировать от легкого дефицита до деменции и представляют собой распространенное и серьезное долгосрочное последствие инсульта. КН могут развиваться как после ишемического, так и после геморрагического инсульта. Риск и время возникновения ПИКН могут зависеть от различных факторов. Наличие ПИКН независимо связано с более низким качеством жизни после инсульта, более высоким уровнем смертности. Понимание патогенеза ПИКН имеет основополагающее значение для снижения глобального бремени инсульта. Лечение ПИКН включает в себя междисциплинарный подход к устранению основных причин и когнитивных симптомов. Стратегии ведения сосредоточены на когнитивной реабилитации, фармакологических вмешательствах, устранении изменяемых факторов риска.

ишемический и геморрагический инсульткогнитивные нарушенияфакторы рискапатофизиологиятерапевтические подходыischemic and hemorrhagic strokecognitive impairmentrisk factorspathophysiologytherapeutic approachesСтатья спонсируется компанией «Озон»The article is sponsored by OzonReferencesFeigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132-44. doi: 10.1177/17474930241308142Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132-44. doi: 10.1177/17474930241308142Gong L, Yao YY, Wang Y. Investigation on the survival status and traditional Chinese medicine characteristics of ischemic stroke patients of different genders. J Integr Tradit Chin West Med Cardio-Cerebrovasc Dis. 2020;18(15):2404-9. doi: 10.12102/j.issn.1672-1349.2020.15.007Gong L, Yao YY, Wang Y. Investigation on the survival status and traditional Chinese medicine characteristics of ischemic stroke patients of different genders. J Integr Tradit Chin West Med Cardio-Cerebrovasc Dis. 2020;18(15):2404-9. doi: 10.12102/j.issn.1672-1349.2020.15.007Obaid M, Douiri A, Flach C, et al. Can we prevent poststroke cognitive impairment? An umbrella review of risk factors and treatments. BMJ Open. 2020;10(9):e037982. doi: 10.1136/bmjopen-2020-037982Obaid M, Douiri A, Flach C, et al. Can we prevent poststroke cognitive impairment? An umbrella review of risk factors and treatments. BMJ Open. 2020;10(9):e037982. doi: 10.1136/bmjopen-2020-037982El Husseini N, Katzan IL, Rost NS, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the american heart association/american stroke association. Stroke. 2023;54(6):e272e291. doi: 10.1161/STR.0000000000000430El Husseini N, Katzan IL, Rost NS, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the american heart association/american stroke association. Stroke. 2023;54(6):e272e291. doi: 10.1161/STR.0000000000000430Munthe-Kaas R, Aam S, Ihle-hansen H, et al. Impact of different methods defining poststroke neurocognitive disorder: The Nor-COAST study. Alzheimers Dement. 2020;6(1):e12000. doi: 10.1002/trc2.12000Munthe-Kaas R, Aam S, Ihle-hansen H, et al. Impact of different methods defining poststroke neurocognitive disorder: The Nor-COAST study. Alzheimers Dement. 2020;6(1):e12000. doi: 10.1002/trc2.12000Sachdev PS, Brodaty H, Valenzuela MJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney stroke study. Dement Geriatr Cogn Disord. 2006;21(5-6):275-83. doi: 10.1159/000091434Sachdev PS, Brodaty H, Valenzuela MJ, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney stroke study. Dement Geriatr Cogn Disord. 2006;21(5-6):275-83. doi: 10.1159/000091434Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4:160-71. doi: 10.1177/2396987318825484Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4:160-71. doi: 10.1177/2396987318825484Вербицкая СВ, Парфенов ВА, Решетников ВА и др. Постинсультные когнитивные нарушения (результаты 5-летнего наблюдения). Неврология, нейропсихиатрия, психосоматика. 2018;10(1):37-42. doi: 10.14412/2074-2711-2018-1-37-42Verbitskaya SV, Parfenov VA, Reshetnikov VA, et al. Post-stroke cognitive impairment (results of a 5-year follow-up). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):37-42 (In Russ.). doi: 10.14412/2074-2711-2018-1-37-42Delavaran H, Jönsson A, Lövkvist H, et al. Cognitive function in stroke survivors: a 10-year follow-up study. Acta Neurol Scand. 2017;136(3):187-94. doi: 10.1111/ane.12709Delavaran H, Jönsson A, Lövkvist H, et al. Cognitive function in stroke survivors: a 10-year follow-up study. Acta Neurol Scand. 2017;136(3):187-94. doi: 10.1111/ane.12709Brewer L, Mellon L, Hall P, et al. Secondary prevention after ischaemic stroke: the ASPIRE-S study. BMC Neurol. 2015;15:216. doi: 10.1186/s12883-015-0466-2Brewer L, Mellon L, Hall P, et al. Secondary prevention after ischaemic stroke: the ASPIRE-S study. BMC Neurol. 2015;15:216. doi: 10.1186/s12883-015-0466-2Jia WL, Liu Q, Li SQ. Correlation between hemoglobin level at admission and post-stroke cognitive impairment in acute stroke patients. China Acad J. 2021;56(12):1346-9. doi: 10.3969/j.issn.1008-1070.2021.12.020Jia WL, Liu Q, Li SQ. Correlation between hemoglobin level at admission and post-stroke cognitive impairment in acute stroke patients. China Acad J. 2021;56(12):1346-9. doi: 10.3969/j.issn.1008-1070.2021.12.020Gallucci L, Sperber C, Guggisberg AG, et al. Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment. Int J Stroke. 2024;19(8):888-97. doi: 10.1177/17474930241238637Gallucci L, Sperber C, Guggisberg AG, et al. Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment. Int J Stroke. 2024;19(8):888-97. doi: 10.1177/17474930241238637Dec-Cwiek M, Wrona P, Homa T, et al. Incidence and Factors Associated With Cognitive Impairment 90 Days After First Ever Ischemic Stroke. Int J Geriatr Psychiatry. 2025;40(5):e70087. doi: 10.1002/gps.70087Dec-Cwiek M, Wrona P, Homa T, et al. Incidence and Factors Associated With Cognitive Impairment 90 Days After First Ever Ischemic Stroke. Int J Geriatr Psychiatry. 2025;40(5):e70087. doi: 10.1002/gps.70087Moulin S, Labreuche J, Bombois S, et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 2016;15:820-9. doi: 10.1016/S14744422(16)00130-7Moulin S, Labreuche J, Bombois S, et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 2016;15:820-9. doi: 10.1016/S14744422(16)00130-7Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002;59:1750-8. doi: 10.1212/01.wnl.0000035748.91128.c2Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002;59:1750-8. doi: 10.1212/01.wnl.0000035748.91128.c2Springer MV, Schmidt JM, Wartenberg KE, et al. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65:1043-50. doi: 10.1227/01.NEU.0000359317.15269.20Springer MV, Schmidt JM, Wartenberg KE, et al. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65:1043-50. doi: 10.1227/01.NEU.0000359317.15269.20Пизова НВ, Пизов АВ. Ишемический инсульт у мужчин и женщин в разные возрастные периоды. Поликлиника. 2025;(13):9-12. Доступно по ссылке: https://poliklin.ru/pdf/2025/Nevro_Kardio_ZhDA_1_2025_obsh_fin+.pdfPizova NV, Pizov AV. Ischemic stroke in men and women at different age periods. Poliklinika. 2025;(1-3):9-12 (In Russ.). Available at: https://poliklin.ru/pdf/2025/Nevro_Kardio_Zh DA_1_2025_obsh_fin+.pdfWeterings RP, Kessels RP, de Leeuw FE, Piai V. Cognitive impairment after a stroke in young adults: A systematic review and metaanalysis. Int J Stroke. doi: 10.1177/17474930231159267Weterings RP, Kessels RP, de Leeuw FE, Piai V. Cognitive impairment after a stroke in young adults: A systematic review and metaanalysis. Int J Stroke. doi: 10.1177/17474930231159267Rodriguez Garcia PL, Rodriguez Garcia D. Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 2015;30:223-39. doi: 10.1016/j.nrl.2011.12.014Rodriguez Garcia PL, Rodriguez Garcia D. Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 2015;30:223-39. doi: 10.1016/j.nrl.2011.12.014Lo JW, Crawford JD, Desmond DW, et al. Long-term cognitive decline after stroke: an individual participant data meta-analysis. Stroke. 2022;53(4):1318-27. doi: 10.1161/STROKEAHA.121.035796Lo JW, Crawford JD, Desmond DW, et al. Long-term cognitive decline after stroke: an individual participant data meta-analysis. Stroke. 2022;53(4):1318-27. doi: 10.1161/STROKEAHA.121.035796Contador I, Alzola P, Bermejo-Pareja F, et al. Education and literacy as risk factors of dementia after stroke and transient ischemic attack: nedices study. J Alzheimers Dis. 2022;88(1):291-9. doi: 10.3233/JAD-220109Contador I, Alzola P, Bermejo-Pareja F, et al. Education and literacy as risk factors of dementia after stroke and transient ischemic attack: nedices study. J Alzheimers Dis. 2022;88(1):291-9. doi: 10.3233/JAD-220109Weaver AN, Jaeggi SM. Activity engagement and cognitive performance amongst older adults. Front Psychol. 2021:12:620867. doi: 10.3389/fpsyg.2021.620867Weaver AN, Jaeggi SM. Activity engagement and cognitive performance amongst older adults. Front Psychol. 2021:12:620867. doi: 10.3389/fpsyg.2021.620867Rost NS, Meschia JF, Gottesman R, et al. Cognitive impairment and dementia after stroke: design and rationale for the discovery study. Stroke. 2021;52(8):e499-e516. doi: 10.1161/STROKEAHA.120.031611Rost NS, Meschia JF, Gottesman R, et al. Cognitive impairment and dementia after stroke: design and rationale for the discovery study. Stroke. 2021;52(8):e499-e516. doi: 10.1161/STROKEAHA.120.031611Elendu C, Amaechi DC, Elendu TC, et al. Stroke and cognitive impairment: understanding the connection and managing symptoms. Ann Med Surg (Lond). 2023;85(12):6057-66. doi: 10.1097/MS9.0000000000001441Elendu C, Amaechi DC, Elendu TC, et al. Stroke and cognitive impairment: understanding the connection and managing symptoms. Ann Med Surg (Lond). 2023;85(12):6057-66. doi: 10.1097/MS9.0000000000001441Rajan KB, Aggarwal NT, Schneider JA, et al. Role of apoe E4 allele and incident stroke on cognitive decline and mortality. Alzheimer Dis Assoc Disord. 2016;30(4):318-23. doi: 10.1097/WAD.0000000000000173Rajan KB, Aggarwal NT, Schneider JA, et al. Role of apoe E4 allele and incident stroke on cognitive decline and mortality. Alzheimer Dis Assoc Disord. 2016;30(4):318-23. doi: 10.1097/WAD.0000000000000173Weaver NA, Kuijf HJ, Aben HP, et al. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol. 2021;20(6):448-59. doi: 10.1016/S1474-4422(21)00060-0Weaver NA, Kuijf HJ, Aben HP, et al. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol. 2021;20(6):448-59. doi: 10.1016/S1474-4422(21)00060-0Koton S, Pike JR, Johansen M, et al. Association of ischemic stroke incidence, severity, and recurrence with dementia in the Atherosclerosis Risk in Communities cohort study. JAMA Neurol. 2022;79:271-80. doi: 10.1001/jamaneurol.2021.5080Koton S, Pike JR, Johansen M, et al. Association of ischemic stroke incidence, severity, and recurrence with dementia in the Atherosclerosis Risk in Communities cohort study. JAMA Neurol. 2022;79:271-80. doi: 10.1001/jamaneurol.2021.5080Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the populationbased Oxford Vascular Study. Lancet Neurol. 2019;18:248-58. doi: 10.1016/S1474-4422(18)30442-3Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the populationbased Oxford Vascular Study. Lancet Neurol. 2019;18:248-58. doi: 10.1016/S1474-4422(18)30442-3Drozdowska BA, Elliott E, Taylor-Rowan M, et al. Cardiovascular risk factors indirectly affect acute post-stroke cognition through stroke severity and prior cognitive impairment: a moderated mediation analysis. Alzheimers Res Ther. 2020;12(1):85. doi: 10.1186/s13195-02000653-y.Drozdowska BA, Elliott E, Taylor-Rowan M, et al. Cardiovascular risk factors indirectly affect acute post-stroke cognition through stroke severity and prior cognitive impairment: a moderated mediation analysis. Alzheimers Res Ther. 2020;12(1):85. doi: 10.1186/s13195-02000653-y.Levine DA, Chen B, Galecki AT, et al. Associations between vascular risk factor levels and cognitive decline among stroke survivors. IAMA Netw Open. 2023;6(5):e2313879. doi: 10.1001/jamanetworkopen.2023.13879Levine DA, Chen B, Galecki AT, et al. Associations between vascular risk factor levels and cognitive decline among stroke survivors. IAMA Netw Open. 2023;6(5):e2313879. doi: 10.1001/jamanetworkopen.2023.13879Shang Y, Fratiglioni L, Marseglia A, et al. Association of diabetes with stroke and poststroke dementia: a population-based cohort study. Alzheimers Dement. 2020;16(7):1003-12. doi: 10.1002/alz.12101Shang Y, Fratiglioni L, Marseglia A, et al. Association of diabetes with stroke and poststroke dementia: a population-based cohort study. Alzheimers Dement. 2020;16(7):1003-12. doi: 10.1002/alz.12101Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62(5):810-7. doi: 10.1161/HYPERTENSIONAHA.113.01063Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62(5):810-7. doi: 10.1161/HYPERTENSIONAHA.113.01063Peh A, O'Donnell JA, Broughton BRS, Marques FZ. Gut microbiota and their metabolites in stroke: a double-edged sword. Stroke. 2022;53(5):1788-801. doi: 10.1161/STROKEAHA.121.036800Peh A, O'Donnell JA, Broughton BRS, Marques FZ. Gut microbiota and their metabolites in stroke: a double-edged sword. Stroke. 2022;53(5):1788-801. doi: 10.1161/STROKEAHA.121.036800Goralczyk-Binkowska A, Szmajda-Krygier D, Kozlowska E. The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci. 2022;23(19):11245. doi: 10.3390/ijms231911245Goralczyk-Binkowska A, Szmajda-Krygier D, Kozlowska E. The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci. 2022;23(19):11245. doi: 10.3390/ijms231911245Zhou W, Feng H, Tao H, et al. Factors Influencing Poststroke Cognitive Dysfunction: Cross-Sectional Analysis. JMIR Form Res. 2024;8:e59572. doi: 10.2196/59572Zhou W, Feng H, Tao H, et al. Factors Influencing Poststroke Cognitive Dysfunction: Cross-Sectional Analysis. JMIR Form Res. 2024;8:e59572. doi: 10.2196/59572Cerasuolo JO, Mandzia J, Cipriano LE, et al. Intravenous thrombolysis after first-ever ischemic stroke and reduced incident dementia rate. Stroke. 2022;53(4):1170-7. doi: 10.1161/STROKEAHA.121.034969Cerasuolo JO, Mandzia J, Cipriano LE, et al. Intravenous thrombolysis after first-ever ischemic stroke and reduced incident dementia rate. Stroke. 2022;53(4):1170-7. doi: 10.1161/STROKEAHA.121.034969Jokinen H, Melkas S, Ylikoski R, et al. Poststroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288-94. doi: 10.1111/ene.12743Jokinen H, Melkas S, Ylikoski R, et al. Poststroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288-94. doi: 10.1111/ene.12743Xu G, Dong X, Niu X, et al. Cognitive function and prognosis of multimodal neuroimage-guided thrombectomy on mild to moderate anterior circulation infarction patients with broadened therapeutic window: A prospective study. Eur Neurol. 2017;78:257-63. doi: 10.1159/000479735Xu G, Dong X, Niu X, et al. Cognitive function and prognosis of multimodal neuroimage-guided thrombectomy on mild to moderate anterior circulation infarction patients with broadened therapeutic window: A prospective study. Eur Neurol. 2017;78:257-63. doi: 10.1159/000479735De Rubeis G, Ghozy S, Fabiano S, et al. The Effect of Mechanical Thrombectomy on the Incidence of Poststroke Cognitive Impairment: A Systematic Review of Inhomogeneous Literature. Cerebrovasc Dis. 2023;52(6):711-9. doi: 10.1159/000529265De Rubeis G, Ghozy S, Fabiano S, et al. The Effect of Mechanical Thrombectomy on the Incidence of Poststroke Cognitive Impairment: A Systematic Review of Inhomogeneous Literature. Cerebrovasc Dis. 2023;52(6):711-9. doi: 10.1159/000529265Lattanzi S, Coccia M, Pulcini A, et al. Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke. Sci Rep. 2020;10(1):18524. doi: 10.1038/s41598020-75609-1Lattanzi S, Coccia M, Pulcini A, et al. Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke. Sci Rep. 2020;10(1):18524. doi: 10.1038/s41598020-75609-1Silva GS, Lima FO, Camargo EC, et al. Gender differences in outcomes after ischemic stroke: Role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis. 2010;30(5):470-5. doi: 10.1159/000317088Silva GS, Lima FO, Camargo EC, et al. Gender differences in outcomes after ischemic stroke: Role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis. 2010;30(5):470-5. doi: 10.1159/000317088Bonkhoff AK, Karch A, Weber R, et al. Sex differences in acute treatment and early outcomes of acute ischemic stroke. Stroke. 2021;52(2):406-15. doi: 10.1161/STROKEAHA.120.032850Bonkhoff AK, Karch A, Weber R, et al. Sex differences in acute treatment and early outcomes of acute ischemic stroke. Stroke. 2021;52(2):406-15. doi: 10.1161/STROKEAHA.120.032850Gall S, Phan H, Madsen TE, et al. Focused update of sex differences in patient reported outcome measures after stroke. Stroke. 2018;49(3):531-5. doi: 10.1161/STROKEAHA.117.018417Gall S, Phan H, Madsen TE, et al. Focused update of sex differences in patient reported outcome measures after stroke. Stroke. 2018;49(3):531-5. doi: 10.1161/STROKEAHA.117.018417Yu J, Wang J. Effect of post-stroke cognitive impairment and dementia on stroke recurrence and functional outcomes: A systematic review and meta-analysis. PLoS One. 2024;19(12):e0313633. doi: 10.1371/journal.pone.0313633Yu J, Wang J. Effect of post-stroke cognitive impairment and dementia on stroke recurrence and functional outcomes: A systematic review and meta-analysis. PLoS One. 2024;19(12):e0313633. doi: 10.1371/journal.pone.0313633Cicerone KD, Goldin Y, Ganci K, et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100:1515-33. doi: 10.1016/j.apmr.2019.02.011Cicerone KD, Goldin Y, Ganci K, et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100:1515-33. doi: 10.1016/j.apmr.2019.02.011Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a metaanalysis of randomised controlled trials. Lancet Neurol. 2007;6:782-92. doi: 10.1016/S14744422(07)70195-3Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a metaanalysis of randomised controlled trials. Lancet Neurol. 2007;6:782-92. doi: 10.1016/S14744422(07)70195-3Battle CE, Abdul-Rahim AH, Shenkin SD, et al. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2Battle CE, Abdul-Rahim AH, Shenkin SD, et al. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2Swiatkiewicz M, Grieb P. Citicoline for Supporting Memory in Aging Humans. Aging Dis. 2023;14(4):1184-95. doi: 10.14336/AD.2022.0913Swiatkiewicz M, Grieb P. Citicoline for Supporting Memory in Aging Humans. Aging Dis. 2023;14(4):1184-95. doi: 10.14336/AD.2022.0913Gareri P, Castagna A, Cotroneo AM, et al. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421-9. doi: 10.2147/CIA.S87886Gareri P, Castagna A, Cotroneo AM, et al. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421-9. doi: 10.2147/CIA.S87886Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol. 2022;75(5):S1-S89. doi: 10.33588/rn.75s05.2022311Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol. 2022;75(5):S1-S89. doi: 10.33588/rn.75s05.2022311Jasielski P, Piedel F, Piwek M, et al. Application of citicoline in neurological disorders: a systematic review. Nutrients. 2020;12(10):3113. doi: 10.3390/nu12103113Jasielski P, Piedel F, Piwek M, et al. Application of citicoline in neurological disorders: a systematic review. Nutrients. 2020;12(10):3113. doi: 10.3390/nu12103113Fioravanti M, Yanagi M. Cytidinediphospho choline (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269.Fioravanti M, Yanagi M. Cytidinediphospho choline (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269.Cotroneo AM, Castagna A, Putignano S, et al. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging. 2013:8:131-7. doi: 10.2147/CIA.S38420Cotroneo AM, Castagna A, Putignano S, et al. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging. 2013:8:131-7. doi: 10.2147/CIA.S38420Alvarez-Sabin J, Santamarina E, Maisterra O, et al. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci. 2016;17:390. doi: 10.3390/ijms17030390Alvarez-Sabin J, Santamarina E, Maisterra O, et al. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci. 2016;17:390. doi: 10.3390/ijms17030390Bermejo PE, Dorado R, Ascension Zea-Sevilla M. Role of Citicoline in Patients With Mild Cognitive Impairment. Neurosci Insights. 2023:18:26331055231152496. doi: 10.1177/26331055231152496Bermejo PE, Dorado R, Ascension Zea-Sevilla M. Role of Citicoline in Patients With Mild Cognitive Impairment. Neurosci Insights. 2023:18:26331055231152496. doi: 10.1177/26331055231152496Боголепова АН, Бурд СГ, Лебедева АВ, Коваленко ЕА. Опыт применения цитиколина у пациентов с постинсультными когнитивными нарушениями. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):43-8. doi: 10.14412/2074-2711-2020-4-43-48Bogolepova AN, Burd SG, Lebedeva AV, Kovalenko EA. Experience with citicoline in patients with post-stroke cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):43-8 (In Russ.). doi: 10.14412/20742711-2020-4-43-48Gareri P, Castagna A. Citicoline in vascular cognitive impairment. Some latest evidences. Ann Alzheimers Dement Care. 2017;2(1):18-9. doi: 10.17352/aadc.000004Gareri P, Castagna A. Citicoline in vascular cognitive impairment. Some latest evidences. Ann Alzheimers Dement Care. 2017;2(1):18-9. doi: 10.17352/aadc.000004Щепанкевич ЛА, Грибачева ИА, Попова ТФ и др. Клинический опыт применения цитиколина при умеренных когнитивных нарушениях сосудистого генеза. Неврология, нейропсихиатрия, психосоматика. 2023;15(4):74-9. doi: 10.14412/2074-2711-2023-4-74-79Shchepankevich LA, Gribacheva IA, Popova TF, et al. Clinical experi ence with the use of citicoline in mild cognitive impairment of vascular origin. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(4):749 (In Russ.). doi: 10.14412/2074-2711-2023-4-74-79Щепанкевич ЛА, Рерих КВ, Пономарева МС и др. Астения и сосудистые когнитивные нарушения у молодых пациентов после инсульта. Неврология, нейропсихиатрия, психосоматика. 2024;16(5):69-76. doi: 10.14412/2074-27112024-5-69-76Shchepankevich LA, Rerikh KV, Ponomareva MS, et al. Asthenia and vascular cognitive impairment in young patients after stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(5):69-76 (In Russ.). doi: 10.14412/2074-2711-2024-5-69-76

The authors declare that there are no conflicts of interest present.